產(chǎn)品[
人外周血**細(xì)胞
]資料
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱:
人外周血**細(xì)胞
產(chǎn)品型號(hào):
CCL-120
產(chǎn)品廠商:
美國(guó)標(biāo)準(zhǔn)生物品收藏中心（ATCC）
產(chǎn)品文檔:
無(wú)相關(guān)文檔
簡(jiǎn)單介紹
CCL-120 CCRF-SD 人外周血**細(xì)胞ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞|貼壁細(xì)胞|懸浮細(xì)胞|；細(xì)胞庫(kù)管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和Z優(yōu)培養(yǎng)條件！
人外周血**細(xì)胞
的詳細(xì)介紹
CCL-120 CCRF-SD 人外周血**細(xì)胞
|
|
CCL-120?
|
|
$338.00
|
|
|
CCRF-SB [CCRF SB]
|
|
|
GE Foley
|
|
Biosafety Level:
|
2 [Cells Contain HERPESVIRUS ]
|
|
|
frozen
|
|
Medium & Serum:
|
See Propagation
|
|
|
suspension
|
|
|
Homo sapiens (human)
|
|
|
lymphoblast
|
|
|
Organ: peripheral blood
Disease: acute lymphoblastic leukemia
Cell Type: B lymphoblast;
|
|
|
In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
|
|
|
|
|
HLA A1, A2, B12, B17, Cw2
|
|
|
Amelogenin: X,Y
CSF1PO: 10,12
D13S317: 10,12
D16S539: 9,13
D5S818: 11,12
D7S820: 11,12
THO1: 9,10
TPOX: 8
vWA: 18
|
|
|
G6PD, B
|
|
|
11.5 years
|
|
|
male
|
|
|
Caucasian
|
|
|
ATCC complete growth medium: RPMI 1640 medium, 90%; fetal bovine serum, 10% - OR - Iscove's modified Dulbecco's medium, 90%; fetal bovine serum, 10%
Temperature: 37.0°C
|
|
|
Protocol: Cultures can be maintained by addition or replacement of medium. Establish new cultures at 3 X 10(5) viable cells/ml.
Medium Renewal: Add fresh medium (10% to 20% by volume) every 2 to 3 days
|
|
|
derived from same individual:ATCC CCL-120.1
|
|
|
24413: . M.D. Anderson Hospital and Tumor Inst. Monograph. 21: ; 1967.
25967: Adams RA. Formal discussion: the role of transplantation in the experimental investigation of human leukemia and lymphoma. Cancer Res. 27: 2479-2482, 1967. PubMed: 4170381
|
|
